10x Genomics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017
Revenue	618.73	516.41	490.49	298.85	245.89	146.31	71.09
Revenue Growth (YoY)	19.81%	5.28%	64.13%	21.53%	68.06%	105.83%	-
Cost of Revenue	209.41	120.39	74.09	58.47	61.03	28.66	10.56
Gross Profit	409.31	396.02	416.4	240.38	184.86	117.65	60.53
Selling, General & Admin	343.33	298.3	257.56	202.33	130.83	87.94	46.74
Research & Development	270.33	265.67	211.75	123.38	83.1	47.54	32.16
Other Operating Expenses	60.98	0	-0.66	448.82	1.5	92.94	0
Operating Expenses	674.64	563.97	468.65	774.52	215.43	228.42	78.9
Operating Income	-265.33	-167.94	-52.25	-534.14	-30.57	-110.76	-18.38
Interest Expense / Income	0.03	0.48	0.87	1.68	3.08	2.41	0.81
Other Expense / Income	-16.6	-6.45	0.6	-1.35	-2.62	-0.78	-0.45
Pretax Income	-248.76	-161.97	-53.72	-534.48	-31.03	-112.4	-18.74
Income Tax	6.34	4.03	4.51	8.26	0.22	0.09	0.02
Net Income	-255.1	-166	-58.22	-542.73	-31.25	-112.49	-18.76
Shares Outstanding (Basic)	117	114	110	101	39	13	12
Shares Outstanding (Diluted)	117	114	110	101	39	13	12
Shares Change	2.90%	3.18%	9.09%	158.76%	191.89%	15.57%	-
EPS (Basic)	-2.18	-1.46	-0.53	-5.37	-0.80	-8.40	-1.62
EPS (Diluted)	-2.18	-1.46	-0.53	-5.37	-0.80	-8.40	-1.62
Free Cash Flow	-63.8	-165.27	-122.65	-254.56	-8.12	-82.69	-14.46
Free Cash Flow Per Share	-0.55	-1.45	-1.11	-2.52	-0.21	-6.17	-1.25
Gross Margin	66.15%	76.69%	84.89%	80.44%	75.18%	80.41%	85.14%
Operating Margin	-42.88%	-32.52%	-10.65%	-178.74%	-12.43%	-75.70%	-25.85%
Profit Margin	-41.23%	-32.15%	-11.87%	-181.61%	-12.71%	-76.88%	-26.39%
Free Cash Flow Margin	-10.31%	-32.00%	-25.01%	-85.18%	-3.30%	-56.52%	-20.33%
EBITDA	-205.11	-128.49	-24.6	-513.77	-20.89	-106.08	-13.63
EBITDA Margin	-33.15%	-24.88%	-5.01%	-171.92%	-8.49%	-72.50%	-19.17%
Depreciation & Amortization	43.62	33.01	28.25	19.02	7.07	3.91	4.31
EBIT	-248.73	-161.5	-52.85	-532.79	-27.95	-109.99	-17.93
EBIT Margin	-40.20%	-31.27%	-10.77%	-178.28%	-11.37%	-75.17%	-25.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).